Novel formulated food for the elderly

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: China Postdoctoral Science Foundation and 4 more

Human trial1

Outcomes

Ruminococcus

upin humans1+35%

1 study

Novel formulated food for the elderly increases Ruminococcus in humans (+35%).
“Notably, NFFE selectively enriched short-chain fatty acid (SCFA)-producing bacteria (Bifidobacterium ↑42 % and Ruminococcus ↑35 %).”
Human trial8 weeks
Novel formulated food for the elderly regulates specific gut bacterial taxa and improves host physiology
Food research international (Ottawa, Ont.)7 Aug 2025

Latest

Food Research International1 Nov